AgelessRx

AgelessRx

Direct-to-consumer telehealth for longevity treatments

About AgelessRx

Simplify's Rating
Why AgelessRx is rated
C
Rated C on Competitive Edge
Rated B on Growth Potential
Rated D+ on Differentiation

Industries

Consumer Software

Healthcare

Company Size

51-200

Company Stage

N/A

Total Funding

$1

Headquarters

Ann Arbor, Michigan

Founded

2019

Overview

AgelessRx offers telehealth-based longevity care, providing access to prescription medications and therapies aimed at slowing aging and preventing age-related diseases. Its products include Metformin, Low Dose Naltrexone (LDN), NAD+ patches, and Galleri cancer screening, all available through a direct-to-consumer subscription model. Customers complete online consultations with healthcare professionals, receive prescriptions, and have treatments delivered to their homes. The company differentiates itself with science-backed treatment options, educational resources, and a portion of profits directed toward longevity research and advocacy, positioning itself to serve consumers seeking proactive health management. Its goal is to help people extend their healthspan by making preventative anti-aging care more accessible and by supporting scientific progress in longevity.

Simplify Jobs

Simplify's Take

What believers are saying

  • 6,600 patients gained mental clarity; 8,300 boosted energy in 2025.
  • 5,200+ completed clinical studies on therapy efficacy.
  • 82.7% reported improvements by first check-in.

What critics are saying

  • FDA halts GLP-1 microdosing trial for unapproved anti-aging use.
  • Novo Nordisk undercuts prices, captures market in 18 months.
  • Adverse events from Rapamycin trigger lawsuits in 12 months.

What makes AgelessRx unique

  • Offers Rapamycin and microdosed GLP-1s via Stanford PhD-led trials.
  • Infinite Longevity Support targets all 9 aging hallmarks.
  • Provides 30+ diagnostics including NAD+ Nasal Spray.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$0.97

Above

Industry Average

Funded Over

0 Rounds

Benefits

Flexible Work Hours

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

6%
Decrypt
May 2nd, 2025
Dementia Risk Tied To Biological Age In New Study

In brief The research showed that biological age can be a stronger predictor of dementia risk than chronological age.According to a February 2025 report by the National Institutes of Health, more than 6 million Americans are living with dementia.Experts say tracking biological age helps improve the understanding of health and aging, while also identifying early risks of diseases such as dementia.Decrypt’s Art, Fashion, and Entertainment Hub. Discover SCENEAging faster on the inside—even if you're still young on the outside—could raise your risk of dementia, a new study from Zhengzhou University in China found.The research showed that biological age, or how well the body is functioning, can be a stronger predictor of dementia risk than chronological age.The study, published on Wednesday in Neurology, the journal of the American Academy of Neurology, used data from the UK Biobank and tracked 280,918 people with an average age of 57 over a 14-year period.It found that faster biological aging was linked to a 14% to 15% higher risk of developing dementia.“With the rising impact of dementia around the world, identifying risk factors and implementing preventive measures is essential,” lead researcher Dr. Yacong Bo said. “While none of us can change our chronological age, we can influence our biological age through lifestyle factors such as diet and exercise.”To assess biological aging, Chinese researchers used two metrics: Klemera–Doubal Method Biological Age (KDM-BA), which uses blood test results; and PhenoAge, which draws on clinical data tied to aging and mortality.For each increase in the rate of biological aging, as measured by KDM-BA and PhenoAge, the risk of dementia rose."These brain structure changes explain some, but not all, of the association between advanced biological age and dementia," Bo continued. "These results support the hypothesis that advanced biological age may contribute to the development of dementia by causing a widespread change in brain structures."More than 6 million Americans are living with dementia, which causes about 100,000 deaths annually, according to a February 2025 report by the National Institutes of Health.While dementia has declined 13% per decade due to better education, heart health, and lifestyle, the total number of cases is rising as the population ages, increasing pressure on the healthcare system.In 2020, the number of people worldwide with dementia stood at 55 million, according to the non-profit Alzheimer’s Disease International. By 2030, the number is expected to reach 78 million, and by 2050, it is projected to reach 139 million.Age is often seen as just a number on a calendar, with chronological age referring to the number of years one has been alive

Recently Posted Jobs

Sign up to get curated job recommendations

AgelessRx is Hiring for 2 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →